Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome

Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing

(2015) F. Li et al.   CLINICAL MICROBIOLOGY AND INFECTION

Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus

(2015) S Zhen et al.   GENE THERAPY

Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatocyte Nuclear Factor 6

(2015) Ruidong Hao et al.   JOURNAL OF VIROLOGY

Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease

(2015) Edward M. Kennedy et al.   VIROLOGY

Development and Applications of CRISPR-Cas9 for Genome Engineering

(2014) Patrick D. Hsu et al.   CELL

CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells

(2014) K.-S. Yuen et al.   JOURNAL OF GENERAL VIROLOGY

Coexistence of Hepatitis B Virus Quasispecies Enhances Viral Replication and the Ability To Induce Host Antibody and Cellular Immune Responses

(2014) L. Cao et al.   JOURNAL OF VIROLOGY

Hepatitis B Virus Polymerase Suppresses NF-κB Signaling by Inhibiting the Activity of IKKs via Interaction with Hsp90β

(2014) Dan Liu et al.   PLoS One

AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication

(2014) Nicholas D. Weber et al.   PLoS One

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

(2014) Su-Ru Lin et al.   Molecular Therapy-Nucleic Acids

Targeting Hepatitis B Virus With CRISPR/Cas9

(2014) Christoph Seeger et al.   Molecular Therapy-Nucleic Acids

New therapeutic vaccination strategies for the treatment of chronic hepatitis B

(2014) Jia Liu et al.   VIROLOGICA SINICA

Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases

(2013) Kristie Bloom et al.   MOLECULAR THERAPY

DNA targeting specificity of RNA-guided Cas9 nucleases

(2013) Patrick D Hsu et al.   NATURE BIOTECHNOLOGY

CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity

(2013) Thomas J. Cradick et al.   NUCLEIC ACIDS RESEARCH

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

(2013) Thomas Gaj et al.   TRENDS IN BIOTECHNOLOGY

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

(2013) Hirotaka Ebina et al.   Scientific Reports

First WHO International Reference Panel containing hepatitis B virus genotypes A–G for assays of the viral DNA

(2012) M. Chudy et al.   JOURNAL OF CLINICAL VIROLOGY

TALENs: a widely applicable technology for targeted genome editing

(2012) J. Keith Joung et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Review article: current antiviral therapy of chronic hepatitis B

(2011) W. S. Ayoub et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effects of Interferon-α/β on HBV Replication Determined by Viral Load

(2011) Yongjun Tian et al.   PLoS Pathogens

Significance of hepatitis B virus genotypes and mutations in the development of hepatocellular carcinoma in Asia

(2010) Henry Lik-Yuen Chan   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Development of novel therapeutics for chronic hepatitis B

(2010) You-hua Xie et al.   VIROLOGICA SINICA

HBV Life Cycle: Entry and Morphogenesis

(2009) Stephanie Schädler et al.   Viruses-Basel